HighTower Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

HighTower Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70K	Sell	16,639 -3,281	-16%	-$12.6K	﹤0.01%	3693
2026 Q1	$69.9K	Buy	19,920 +3,770	+23%	+$15.5K	﹤0.01%	3674
2025 Q4	$54.4K	Buy	16,150 +1,150	+8%	+$2.99K	﹤0.01%	3571
2025 Q3	$19.6K	Hold	15,000	–	–	﹤0.01%	3675
2025 Q2	$10.8K	Buy	+15,000	New	+$11.8K	﹤0.01%	3642
2024 Q1	–	Sell	-52,339	Closed	-$601K	–	3824
2023 Q4	$601K	Buy	52,339 +1,849	+4%	+$18.3K	﹤0.01%	2188
2023 Q3	$489K	Buy	50,490 +16,517	+49%	+$162K	﹤0.01%	2247
2023 Q2	$371K	Buy	33,973 +1,284	+4%	+$13.8K	﹤0.01%	2404
2023 Q1	$352K	Buy	+32,689	New	+$366K	﹤0.01%	2342
2021 Q2	–	Sell	-114,480	Closed	-$1.28M	–	3268
2021 Q1	$1.28M	Buy	+114,480	New	+$1.21M	﹤0.01%	1438

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

HighTower Advisors's IRWD Position: Q2 2026 in Review

HighTower Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 16% in Q2 2026, selling an estimated $12.6K and leaving 16,639 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #3693.

HighTower Advisors first reported a position in IRWD in Q1 2021 and has held it in 10 quarters since. The position peaked at $1.28M in Q1 2021. 71 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

HighTower Advisors held 16,639 shares of Ironwood Pharmaceuticals worth $70K as of Q2 2026.
HighTower Advisors sold 3,281 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $12.6K.
Ironwood Pharmaceuticals made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3693 holding.
HighTower Advisors first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 10 quarters since.
HighTower Advisors's Ironwood Pharmaceuticals position peaked at $1.28M in Q1 2021.
71 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.